{"id":"https://genegraph.clinicalgenome.org/r/66f50ac4-c2bf-4390-b1de-1412f8a5657dv2.0","type":"EvidenceStrengthAssertion","dc:description":"*SOX17* was first reported in relation to autosomal dominant pulmonary arterial hypertension (PAH) as a part of the UK NIHR PAH cohort study (PMID:30527956). Since then, subsequent studies have confirmed the role of *SOX17* in PAH. *SOX17* encodes a transcription factor specific to endothelial cells which is believed to play an important role in cardiovascular development (PMID:36205124). Twenty-one variants (13 missense, 1 nonsense, 7 frameshift) reported in 23 IPAH probands in 6 publications (PMIDs: 29650961, 30029678, 30044643, 30578397, 33952808, 31727138) are included in this curation. The mechanism of pathogenicity appears to be loss of function. This gene-disease relationship is also supported by expression studies and in vitro functional assays (PMIDs:24153254, 33952808, 29650961). Graf et al. observed SOX17 protein predominantly located within the endothelial cells of plexiform lesions in the lung samples of patients with PAH (PMID:29650961). Furthermore, Corado et al. reported exclusive expression of SOX17 in the endothelial pulmonary arterioles of mice (PMID:24153254). Finally, Wang et al. created a *SOX17* mutant construct (p.Gln127Ter) in COS-7 cells. The *SOX17* variant resulted in a repression of *NOTCH-1* activation and then rescued by a WT copy of *SOX17.*\nIn summary, *SOX17* is definitively associated with autosomal dominant PAH. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen PAH Gene Curation Expert Panel on the meeting date 08/30/22 (SOP Version 9).\n\nSOX17-related PAH may also include congenital heart disease (CHD). On January 2, 2024, the CHD GCEP independently evaluated SOX17 for PAH that includes CHD. Types of cardiac anomalies found in affected individuals with SOX17 variants include atrial septal defect, ventricular septal defect, and atrioventricular canal defect. Nineteen variants (missense, nonsense, frameshift) identified in at least 20 PAH-CHD probands have been reported (PMIDs: 30029678, 33794346, 35618278, 37895315). SOX17-related PAH-CHD is associated with an earlier onset than isolated PAH. \n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/66f50ac4-c2bf-4390-b1de-1412f8a5657d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/8d47cc1b-9fe0-4f2f-9415-1490d81a5ca3","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:sopChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/8d47cc1b-9fe0-4f2f-9415-1490d81a5ca3_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10071","date":"2025-10-22T22:38:25.249Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/8d47cc1b-9fe0-4f2f-9415-1490d81a5ca3_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10071","date":"2025-10-22T16:00:00.000Z","role":"Approver"},{"agent":"https://genegraph.clinicalgenome.org/agent/10130","role":"SecondaryContributor"}],"curationReasons":["RecurationNewEvidence"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d47cc1b-9fe0-4f2f-9415-1490d81a5ca3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d47cc1b-9fe0-4f2f-9415-1490d81a5ca3_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/252389e8-e8cb-4032-87b2-0cca443b2caa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5343387a-109c-4971-8b34-1ed3c6d62f31","type":"Finding","dc:description":"SOX17 is exclusively expressed in the endothelial cells of mouse arteries (not expressed in endothelial cells of mouse veins). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24153254","rdfs:label":"SOX17 expression in mice ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5dd62173-c613-4cad-b26c-2b793f70255d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6954f894-9c01-4719-9497-9f7e2c93e7a9","type":"Finding","dc:description":"SOX17 is predominantly localized to the endothelial cells within plexiform lesions in the lungs of IPAH patients. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","rdfs:label":"SOX17 expression in human ","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8d47cc1b-9fe0-4f2f-9415-1490d81a5ca3_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20127809-d15f-4bbc-abef-25b88fe5efaf","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a5fdd33-cf04-40e0-be2e-29449c400e86","type":"FunctionalAlteration","dc:description":"Notch-1 activation was repressed fourteen-fold and then rescued by a WT copy of SOX17. Furthermore, CTNNB1 inhibition was derepressed by the p.Gln127* mutant. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33952808","rdfs:label":"Functional alteration in non-patient cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8d47cc1b-9fe0-4f2f-9415-1490d81a5ca3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a05ecde-9fb1-4a0a-b10b-ec94d6e1c5c9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a05ecde-9fb1-4a0a-b10b-ec94d6e1c5c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","allele":{"id":"https://genegraph.clinicalgenome.org/r/a4289798-16fd-476c-9b3b-b9496d024934","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.164C>T (p.Pro55Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA177527689"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6bf539f1-5feb-4b60-a863-3c58fd9a21a9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6bf539f1-5feb-4b60-a863-3c58fd9a21a9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e7d01e7-ce1a-47e2-b323-9da75b7d8079","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.1136A>T (p.Tyr379Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4751027"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5ae1a499-eab6-4b45-9c81-91825087654d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ae1a499-eab6-4b45-9c81-91825087654d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30578397","allele":{"id":"https://genegraph.clinicalgenome.org/r/f3a4d2af-d12d-45af-ad57-785e95627f97","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.408G>C (p.Lys136Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024386"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a01f52f4-269d-4fa6-83d2-70fe0e72b2de","type":"EvidenceLine","dc:description":"Frameshift variants typically predicted protein truncation but c.818dup is located in the terminal exon which is likely to escape nonsense-mediated decay. The ClinGen Allele Registry nomenclature (p.Leu274ThrfsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a01f52f4-269d-4fa6-83d2-70fe0e72b2de_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30578397","allele":{"id":"https://genegraph.clinicalgenome.org/r/6bb4da8e-3d35-4f6d-bb35-87d0bb929c88","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.818dup (p.Leu274ThrfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332512"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9c13ab89-4e37-499d-bb0b-66db905e1f71","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c13ab89-4e37-499d-bb0b-66db905e1f71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","allele":{"id":"https://genegraph.clinicalgenome.org/r/5875c1d4-e579-4352-b5be-999fd4968682","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.1082C>A (p.Thr361Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4751017"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/47546bef-edca-4e65-b5f1-4e0fc281f627","type":"EvidenceLine","dc:description":"Variant c.75_79del is upstream of the last 50 bps in exon 1 (2 total), and is therefore predicted to undergo NMD. The ClinGen Allele Registry nomenclature (p.Leu167TrpfsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47546bef-edca-4e65-b5f1-4e0fc281f627_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30029678","allele":{"id":"https://genegraph.clinicalgenome.org/r/846e55ae-e1ee-477a-aa7f-4e172dcc0f8e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.75_79del (p.Leu27ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332763"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e2557c0b-9d33-4b75-a026-0cdf480c9092","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2557c0b-9d33-4b75-a026-0cdf480c9092_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","allele":{"id":"https://genegraph.clinicalgenome.org/r/0a5c9f23-a836-4fdf-a5bd-67d13c98e000","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.419G>C (p.Arg140Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024408"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/47171fe1-fc40-43a9-9796-e6c5eafe7cfe","type":"EvidenceLine","dc:description":"Frameshift variants typically predicted protein truncation but c.365-366del is located in the terminal exon which is likely to escape nonsense-mediated decay. The ClinGen Allele Registry nomenclature (p.Glu122AlafsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47171fe1-fc40-43a9-9796-e6c5eafe7cfe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/269e773f-aa4a-4553-bcc6-d8abbfb70d3a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.365_366del (p.Glu122AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332841"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1a5da9b5-a980-4ed5-a7a0-b50f3788abf2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a5da9b5-a980-4ed5-a7a0-b50f3788abf2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30029678","allele":{"id":"https://genegraph.clinicalgenome.org/r/c605427b-4b5e-4b91-a8ea-8678256d6704","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.317G>T (p.Trp106Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024186"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6af2f902-7d60-4d02-8b1f-629e77a7db3d","type":"EvidenceLine","dc:description":"Frameshift variants typically predicted protein truncation but c.499-520del is located in the terminal exon which is likely to escape nonsense-mediated decay. The ClinGen Allele Registry nomenclature (p.Leu167TrpfsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6af2f902-7d60-4d02-8b1f-629e77a7db3d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcf39042-657b-4665-8330-2ff26318e4b6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.499_520del (p.Leu167TrpfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915945692"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5f917fc3-fc5a-4178-b176-26e11fbacee0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f917fc3-fc5a-4178-b176-26e11fbacee0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","allele":{"id":"https://genegraph.clinicalgenome.org/r/ee118934-1bbf-4058-b599-ca87498312cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.394C>G (p.His132Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024350"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e2aceba2-2ce7-488b-b15f-803bf259303d","type":"EvidenceLine","dc:description":"Frameshift variants typically predicted protein truncation but c.499-520del is located in the terminal exon which is likely to escape nonsense-mediated decay. The ClinGen Allele Registry nomenclature (p.Leu167TrpfsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2aceba2-2ce7-488b-b15f-803bf259303d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30029678","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcf39042-657b-4665-8330-2ff26318e4b6"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b406c3d7-39b9-4e35-a783-92362750a281","type":"EvidenceLine","dc:description":"Frameshift variants typically predicted protein truncation but c.696del is located in the terminal exon which is likely to escape nonsense-mediated decay. The ClinGen Allele Registry nomenclature (p.Asp233ThrfsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b406c3d7-39b9-4e35-a783-92362750a281_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30578397","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf8877e6-08bd-4b92-abf5-8ddcb116e39a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.696del (p.Asp233ThrfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332511"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/459bd1ca-bff5-48b0-b5dd-6f13c55a60f9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/459bd1ca-bff5-48b0-b5dd-6f13c55a60f9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","allele":{"id":"https://genegraph.clinicalgenome.org/r/3dc9db78-0df8-4478-bc9f-1233ce432b66","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.397C>T (p.Pro133Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024357"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/06ea0dd2-bae3-4bb6-89ea-7af171df34b7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06ea0dd2-bae3-4bb6-89ea-7af171df34b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30044643","allele":{"id":"https://genegraph.clinicalgenome.org/r/4726babf-f361-4983-abfa-4b7bb94652be","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.397C>G (p.Pro133Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024358"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c473a246-7dc7-408a-9495-d929459f9a03","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c473a246-7dc7-408a-9495-d929459f9a03_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/cf9e7603-b61b-45e5-b707-7fc06a54a4af","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.418C>T (p.Arg140Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024407"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f8c1b09c-9b71-47f7-9188-c201a3739794","type":"EvidenceLine","dc:description":"Frameshift variants typically predicted protein truncation but c.499-520del is located in the terminal exon which is likely to escape nonsense-mediated decay. The ClinGen Allele Registry nomenclature (p.Leu167TrpfsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8c1b09c-9b71-47f7-9188-c201a3739794_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcf39042-657b-4665-8330-2ff26318e4b6"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ee629760-42f9-470e-b745-0a09bcf1e423","type":"EvidenceLine","dc:description":"Frameshift variants typically predicted protein truncation but c.817dup is located in the terminal exon which is likely to escape nonsense-mediated decay. The ClinGen Allele Registry nomenclature (p.Arg273ProfsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee629760-42f9-470e-b745-0a09bcf1e423_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650961","allele":{"id":"https://genegraph.clinicalgenome.org/r/10286e84-fa37-44b1-bbf7-5b072e6dfea8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.817dup (p.Arg273ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332510"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f53c7776-90a7-4a09-86b0-343160357ae1","type":"EvidenceLine","dc:description":"Predicted protein truncation (p.Gln127Ter), but located in the terminal exon which is likely to escape nonsense-mediated decay.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f53c7776-90a7-4a09-86b0-343160357ae1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33952808","allele":{"id":"https://genegraph.clinicalgenome.org/r/d2fa2b2d-341f-45b9-a9e3-e94d26b8d65b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.379C>T (p.Gln127Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024313"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/38bbc57c-2a3c-4ad9-b582-e83c12a62b0d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38bbc57c-2a3c-4ad9-b582-e83c12a62b0d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3a91fc9-7c78-4047-a932-238e1055ba0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.392A>G (p.Asp131Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024346"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d4d8e354-825f-410b-a31e-a6e47243c580","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4d8e354-825f-410b-a31e-a6e47243c580_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/3359ec4c-28cf-4cdc-ae10-787325c98512","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.1190C>T (p.Ser397Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371026011"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0e5f315c-bc7f-4752-b3f3-980f1f567f63","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e5f315c-bc7f-4752-b3f3-980f1f567f63_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30578397","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fa74661-5b0d-4603-a509-9658d0d57d23","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.361G>A (p.Ala121Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA371024278"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ae4ad65e-2d10-4494-ba13-0204ad4a6626","type":"EvidenceLine","dc:description":"Frameshift variants typically predicted protein truncation but c.1224del is located in the terminal exon which is likely to escape nonsense-mediated decay. The ClinGen Allele Registry nomenclature (p.Cys409AlafsTer?) indicates that the new reading frame does not encounter a new translation termination (stop) codon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae4ad65e-2d10-4494-ba13-0204ad4a6626_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/4d911e4a-2781-46bc-9fbe-e54d00abf8f6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_022454.4(SOX17):c.1224del (p.Cys409AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332842"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.8}],"evidenceStrength":"Definitive","sequence":12097,"specifiedBy":"GeneValidityCriteria11","strengthScore":13.3,"subject":{"id":"https://genegraph.clinicalgenome.org/r/71bcWIIOgwk","type":"GeneValidityProposition","disease":"obo:MONDO_0015924","gene":"hgnc:18122","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_8d47cc1b-9fe0-4f2f-9415-1490d81a5ca3-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}